Illumina and D3b bring genomic data and scalable software to the fight against paediatric cancer and rare disease: San Diego Thursday, April 16, 2026, 11:00 Hrs [IST] Illumina, an ...
According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...
DNA methylation data can be used to estimate biological age, but results across commercial tests differ, raising questions ...
Illumina and the Center for Data-Driven Discovery in Biomedicine launched a large pediatric genomic data initiative focused on rare diseases and cancer. The collaboration will analyze 100,000 whole ...
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO, April 14, 2026 /PRNewswire/ -- Illumina (NASDAQ: ILMN) and the Center ...
The agency's method now incorporates the Illumina MiSeq i100 sequencing platform, and the Microbiology Laboratory Guidebook ...
Zacks Investment Research on MSN
Three best genomics stocks for your portfolio in 2026
An updated edition of the Feb. 20, 2026, article. Genomics involves a thorough study of genomes (an organism’s complete set ...
Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...
Human papillomavirus (HPV) is a double-stranded circular DNA virus with a genome of approximately 7–8 kb. This study aimed to ...
I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...
Stanford develops protein-to-DNA method enabling high-throughput protein sequencing Technique detects up to 1,000 times more ...
Dr. Cande Rogert discusses emerging trends in sequencing and how new genomic technologies are shaping multiomics and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results